Status:
NOT_YET_RECRUITING
Improving Lipid Optimization Quality and Treatment Options in ASCVD
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Hypercholesterolemia
ASCVD
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The goal of this project is to study different approaches to improve the utilization of guideline directed medicines to lower cholesterol in patients with or at high risk of atherosclerosis (cholester...
Detailed Description
This project will include approximately 300 patients who, based on current guidelines, would benefit from optimized lipid management. The project is testing the most effective methods to notify provid...
Eligibility Criteria
Inclusion
- \>18 years old and \<=95 years old
- Established Atherosclerotic Cardiovascular Disease
- Diabetes
- Possible Familial Hypercholesterolemia (FH)
- High-Risk Primary Prevention
Exclusion
- No PCP, cardiologist, endocrinologist, or nephrologist at MGB
- ESRD on dialysis
- Enrolled in a hospice program
- Advanced dementia
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06960655
Start Date
August 1 2025
End Date
November 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115